Canaan Inc. (NASDAQ: CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that the Company will participate in the following investor...

- Data from pivotal dose level demonstrates long-term, sustained reductions in CSF levels of HS D2S6, a key biomarker of brain disease in MPS II - 80% of patients who received the pivotal dose...

TrinaTracker, a division of Trinasolar specializing in smart solar tracking solutions, has showcased its upgraded version of the Vanguard 1P smart tracking solution at the prestigious Intersolar...

ESCRS presentations will feature clinical data on the ViaLase® Laser, which recently received CE Mark approval in the European Union ALISO VIEJO, Calif., Sept. 3, 2024 /PRNewswire/ -- ViaLase,...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, ("NRx," the "Company") and HOPE Therapeutics, Inc., a medical and technology driven company and wholly-owned...